Molecular adsorbent recirculating system: Albumin dialysis-based extracorporeal liver assist device

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue SUPPL. 3, 2002, Pages

  Kapoor, Dharmesh ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Acute liver failure; Acute on chronic liver failure; Albumin dialysis; Hepatic encephalopathy; Hepatorenal syndrome; Liver assist device

Indexed keywords

ALBUMIN;

ARTIFICIAL LIVER; BRAIN FUNCTION; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DETOXIFICATION; DEVICE; DISEASE SEVERITY; HEMODIALYSIS; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HUMAN; INTRACRANIAL PRESSURE; KIDNEY FUNCTION; LIVER FAILURE; LIVER FUNCTION; MAINTENANCE THERAPY; METASTASIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SAFETY; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS TRANSMISSION;

EID: 0036454564     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.17.s3.14.x     Document Type: Conference Paper

References (32)

1. Hoofnagle JH, Carithers RL, Shapiro C, Ascher N. Fulminant hepatic failure: Summary of a workshop. Hepatology 1995; 21: 240-4.
2. O'Grady JG, Schalm SW, Williams R. Acute liver failure: Redefining the syndromes. Lancet 1993; 342: 273-5.
3. Jalan R, Williams R. Acute on chronic liver failure: Pathophysiologic basis of therapeutic options. Blood Purif. 2002; 20: 252-61.
4. Rozga J. Extracorporeal support of the failing liver. Med. Sci. Monit. 2001; 7 (Suppl. 1): 78-90.
5. Sechser A, Osorio J, Freise C, Osorio RW. Artificial liver support devices for fulminant liver failure. Clin. Liver Dis. 2001; 5: 415-30.
6. Sussman NL, Chong MG, Koussayer T et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992; 16: 60-5.
7. Janke J, Gerlach J, Kardassis D et al. Effect of a hybrid liver support system on cardiopulmonary function in healthy pigs. Int. J. Artif. Organs 1997; 20: 570-6.
8. Rozga J, Podesta L, LePage E et al. Control of cerebral edema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993; 342: 898-9.
9. Ellis AJ, Hughes RD, Wendon JA et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24: 1446-51.
10. Driscoll DF, Bistrian BR, Jenkins RL et al. Development of metabolic alkalosis after massive transfusion during orthotopic liver transplantation. Crit. Care Med. 1987; 15: 905-8.
11. Hirasawa H, Sugai T, Ohtake Y et al. Blood purification for prevention and treatment of multiple organ failure. World J. Surg. 1996; 20: 482-6.
12. Kiley JE, Pender JC, Welch HF et al. Ammonia intoxication treated by hemodialysis. N. Engl. J. Med. 1958; 259: 1156-9.
13. Gimson AE, Braude S, Mellon PJ et al. Earlier charcoal hemoperfusion in fulminant hepatic failure. Lancet 1982; 2: 681-3.
14. Redeker AG, Yamahiro HS. Controlled trial of exchange-transfusion therapy in fulminant hepatitis. Lancet 1973; 1: 3-6.
15. Kramer L, Gendo A, Madl C et al. Biocompatibility of a cuprophanecharcoal based detoxification device in cirrhotic patients with hepatic encephalopathy. Am. J. Kidney Dis. 2000; 36: 1193-200.
16. Hughes R., Ton HY, Langley P et al. Albumin-coated amberlite XAD 7 resin for hemoperfusion in acute liver failure. Part II. In vivo evaluation. Artif. Organs 1979; 3: 23.
17. Stange J, Mitzner SR, Risler T et al. Molecular adsorbent recycling system (MARS): Clinical results of a new membrane based blood purification system for bioartificial liver support. Artif. Organs 1999; 23: 319-30.
18. Stange J, Mitzner SR. A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver. Int. J. Artif. Organs 1996; 19: 677-91.
19. Mitzner SR, Klammt S, Peszynski P et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent Recirculating system. Ther. Apheresis 2001; 5: 417-22.
20. Sorkine P, Abraham BR, Szold O et al. Role of molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit. Care Med. 2001; 29: 1332-6.
21. Schmidt LE, Svendsen LB, Sorensen VR, Hansen BA, Larsen FS. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbent recirculating system in patients with acute on chronic liver failure. Liver Transpl. 2001; 7: 709-12.
22. Novelli G, Rossi M, Pretagostini R et al. Use of MARS in the treatment of acute liver failure: Preliminary monocentric experience. Transplant. Proc. 2001; 33: 1942-4.
23. Stamler JS, Jaraki O, Osborne J et al. Nitric oxide circulates in mammalian plasma primarily as an s-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA 1992; A89: 7674-7.
24. Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Noldge-Schomburg G. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J. Am. Soc. Nephrol. 2001; 12: S75-82.
25. Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M. Albumin dialysis: Effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: A new possibility for the elimination of protein bound toxins. J. Hepatol. 1999; 31: 1080-5.
26. Mitzner SR, Stange J, Klammt S et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl. 2000; 6: 277-86.
27. Stange J, Mitzner SR, Klammt S et al. Liver support by extracorporeal blood purification: A clinical observation. Liver Transpl. 2000; 6: 603-13.
28. Awad SS, Swaniker F, Magee J, Punch J, Bartlett RH. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 2001; 130: 354-62.
29. Kapoor D, Williams R, Jalan R. MARS: A new treatment for hepatorenal failure. Gastroenterology 2000; 119: 1799-800.
30. Lamesch P, Jost U, Schreiter L, Beier O, Fangmann J, Hauss J. Molecular adsorbent recirculating system in patients with liver failure. Transplant. Proc. 2001; 33: 3480-2.
31. Seige M, Kreymann B, Jeschke B, Schweigart U, Kopp KF, Classen M. Long term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis. Transplant. Proc. 1999; 31: 1371-5.
32. Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R. Albumin dialysis using the molecular adsorbent recirculating system. Curr. Opin. Nephrol. Hypertens. 2001; 10: 777-83.